Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Manon Fabregue"'
Autor:
Rita C. Acúrcio, Ron Kleiner, Daniella Vaskovich‐Koubi, Bárbara Carreira, Yulia Liubomirski, Carolina Palma, Adva Yeheskel, Eilam Yeini, Ana S. Viana, Vera Ferreira, Carlos Araújo, Michael Mor, Natalia T. Freund, Eran Bacharach, João Gonçalves, Mira Toister‐Achituv, Manon Fabregue, Solene Matthieu, Capucine Guerry, Ana Zarubica, Sarit Aviel‐Ronen, Helena F. Florindo, Ronit Satchi‐Fainaro
Publikováno v:
Advanced Science, Vol 11, Iss 40, Pp n/a-n/a (2024)
Abstract The first approved vaccines for human use against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are nanotechnology‐based. Although they are modular, rapidly produced, and can reduce disease severity, the currently availa
Externí odkaz:
https://doaj.org/article/b5734eacdf3b49c7be9c99d042cb5913
Autor:
Séverin Coléon, Aurélie Wiedemann, Mathieu Surénaud, Christine Lacabaratz, Sophie Hue, Mélanie Prague, Minerva Cervantes-Gonzalez, Zhiqing Wang, Jerome Ellis, Amandine Sansoni, Camille Pierini, Quentin Bardin, Manon Fabregue, Sarah Sharkaoui, Philippe Hoest, Léa Dupaty, Florence Picard, Marwa El Hajj, Mireille Centlivre, Jade Ghosn, Rodolphe Thiébaut, Sylvain Cardinaud, Bernard Malissen, Gérard Zurawski, Ana Zarubica, Sandra M. Zurawski, Véronique Godot, Yves Lévy
Publikováno v:
EBioMedicine, Vol 80, Iss , Pp 104062- (2022)
Summary: Background: There is an urgent need of a new generation of vaccine that are able to enhance protection against SARS-CoV-2 and related variants of concern (VOC) and emerging coronaviruses. Methods: We identified conserved T- and B-cell epitop
Externí odkaz:
https://doaj.org/article/7c4c51eefde4479983b08dc65c09880e
Autor:
Quentin Pagneux, Nathalie Garnier, Manon Fabregue, Sarah Sharkaoui, Sophie Mazzoli, Ilka Engelmann, Rabah Boukherroub, Mary Strecker, Eric Cruz, Peter Ducos, Ana Zarubica, Richard Suderman, Sabine Szunerits
Intranasal treatments, combined with vaccination, has the potential to slow mutational evolution of virusues by reducing transmission and replication. Here we illustrate the development of a SARS-CoV-2 receptor binding domain (RBD) nanoCLAMP and demo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8322c4924f0acc8ccc1249432ae6f49
https://doi.org/10.1101/2023.04.03.535401
https://doi.org/10.1101/2023.04.03.535401
